Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

SNORA42 Promote Oesophageal Squamous Cell Carcinoma Development Through Interacting With Dhx9

View through CrossRef
Abstract Background:Oesophageal squamous cell carcinoma (ESCC) is a high malignant cancer, which is the most common subtype of oesophageal cancer. Small nucleolar RNAs (snoRNAs) are a group of novel non-coding RNAs that have been found play a key role in various cancers. Methods:The expression of SNORA42 in ESCC samples and cell lines was measured by using real-time PCR and a series of in vitro and in vivo assays were performed to determine the function of SNORA42 in ESCC. Furthermore, RNA pull-down assay combined with Mass Spectrometry was applied to identify the protein that is associated with SNORA42. Silencing SNORA42 in ESCC cell followed by Next-Generation mRNA Sequencing was used to investigate the signaling pathway regulated by SNORA42.Results: We identified H/ACA box snoRNA42 (SNORA42) wasupregulated in ESCC and had the potential to be applied as a prognostic marker. Specifically, overexpression of SNORA42 promotedESCCprogressionin vitro and in vivo, whereas knockdown of SNORA42 had opposite effects. We identified SNORA42 interacted with DHX9, which was up-regulated in ESCC and had a positive correlation with the expression of SNORA42. Furthermore, the promotion of SNORA42 on ESCC phenotypes can be reversed by knockdown of DHX9. Mechanically, SNORA42 promoted DHX9 expression by attenuating DHX9 transports into cytoplasm, to protect DHX9 from being ubiquitinated and degraded. From KEGG analysis of Next-Generation Sequencing, the NF-κB pathway was one of the most regulated pathways by SNORA42. SNORA42 enhanced phosphorylation of p65 and this effect could be reversed by NF-κB inhibitor, BAY11-7082. Moreover, SNORA42 activated NF-κB signaling through promotingthe transcriptional co-activator DHX9 interacted with p-p65, inducingNF-κB downstream genes expression. Conclusions:These findings suggest that SNORA42 is up-regulated in ESCC and promotes ESCC developments,partly via interacting with DHX9 and triggering SNORA42/DHX9/p65 axis.
Title: SNORA42 Promote Oesophageal Squamous Cell Carcinoma Development Through Interacting With Dhx9
Description:
Abstract Background:Oesophageal squamous cell carcinoma (ESCC) is a high malignant cancer, which is the most common subtype of oesophageal cancer.
Small nucleolar RNAs (snoRNAs) are a group of novel non-coding RNAs that have been found play a key role in various cancers.
Methods:The expression of SNORA42 in ESCC samples and cell lines was measured by using real-time PCR and a series of in vitro and in vivo assays were performed to determine the function of SNORA42 in ESCC.
Furthermore, RNA pull-down assay combined with Mass Spectrometry was applied to identify the protein that is associated with SNORA42.
Silencing SNORA42 in ESCC cell followed by Next-Generation mRNA Sequencing was used to investigate the signaling pathway regulated by SNORA42.
Results: We identified H/ACA box snoRNA42 (SNORA42) wasupregulated in ESCC and had the potential to be applied as a prognostic marker.
Specifically, overexpression of SNORA42 promotedESCCprogressionin vitro and in vivo, whereas knockdown of SNORA42 had opposite effects.
We identified SNORA42 interacted with DHX9, which was up-regulated in ESCC and had a positive correlation with the expression of SNORA42.
Furthermore, the promotion of SNORA42 on ESCC phenotypes can be reversed by knockdown of DHX9.
Mechanically, SNORA42 promoted DHX9 expression by attenuating DHX9 transports into cytoplasm, to protect DHX9 from being ubiquitinated and degraded.
From KEGG analysis of Next-Generation Sequencing, the NF-κB pathway was one of the most regulated pathways by SNORA42.
SNORA42 enhanced phosphorylation of p65 and this effect could be reversed by NF-κB inhibitor, BAY11-7082.
Moreover, SNORA42 activated NF-κB signaling through promotingthe transcriptional co-activator DHX9 interacted with p-p65, inducingNF-κB downstream genes expression.
Conclusions:These findings suggest that SNORA42 is up-regulated in ESCC and promotes ESCC developments,partly via interacting with DHX9 and triggering SNORA42/DHX9/p65 axis.

Related Results

Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract I003: Inhibitors of DHX9 RNA helicase as synthetic lethal cancer therapeutics
Abstract I003: Inhibitors of DHX9 RNA helicase as synthetic lethal cancer therapeutics
Abstract Over 100 modifications to RNA are known to occur in human cells, where they play critical roles in many aspects of normal cellular physiology, such as cell ...
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Abstract Background Ulceration of the oesophageal squamous mucosa (ulcerative oesophagitis) is a pathological manifestation of gastro-oesophageal...
Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis
Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis
Background:The antiapoptotic and epithelial–mesenchymal transition activities of Twist have been implicated in the neoplastic transformation and the development of metastasis, resp...
Oesophageal atresia: Are “long gap” patients at greater anesthetic risk?
Oesophageal atresia: Are “long gap” patients at greater anesthetic risk?
SummaryBackgroundLong gap oesophageal atresia occurs in approximately 10% of all oesophageal atresia infants and surgical repair is often difficult with significant postoperative c...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...

Back to Top